Cargando…
Orally Deliverable Nanotherapeutics for the Synergistic Treatment of Colitis-Associated Colorectal Cancer
Purpose: Colitis-associated colorectal cancer (CAC) poses substantial challenges for effective treatment. Currently, there is a considerable need for the development of orally bioavailable dosage forms that enable the safe and effective delivery of therapeutic drugs to local diseased lesions in the...
Autores principales: | Han, Weidong, Xie, Binbin, Li, Yiran, Shi, Linlin, Wan, Jianqin, Chen, Xiaona, Wang, Hangxiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831307/ https://www.ncbi.nlm.nih.gov/pubmed/31695780 http://dx.doi.org/10.7150/thno.38081 |
Ejemplares similares
-
Orally Deliverable Dual-Targeted Pellets for the Synergistic Treatment of Ulcerative Colitis
por: Tang, Xiaomeng, et al.
Publicado: (2021) -
Editorial: Oral Nanotherapeutics for Colon Diseases
por: Duan, Lian, et al.
Publicado: (2021) -
Quantitative self-assembly of pure drug cocktails as injectable nanomedicines for synergistic drug delivery and cancer therapy
por: Chen, Xiaona, et al.
Publicado: (2021) -
A nanotherapeutic strategy that engages cytotoxic and immunosuppressive activities for the treatment of cancer recurrence following organ transplantation
por: Yang, Zhentao, et al.
Publicado: (2023) -
Self-assembling prodrug nanotherapeutics for synergistic tumor targeted drug delivery
por: Wang, Zhiren, et al.
Publicado: (2020)